![](https://investorshub.advfn.com/uicon/591374.png?cb=1485035485)
Thursday, March 02, 2017 5:06:53 PM
GW*H has a new inhaler type device, like the kind for certain asthma meds.
OWCP has the topical cream, sublingual tablet, and others.
GW*H will have the right delivery system for meds which you want in the blood system via the lungs, while OWCP will go topical and via the blood system via the mouth.
Different delivery systems for different indications.
Know What You Own. My posts should not be construed as investment advice.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM